| We are looking overall for urgent contributions related to COVID-19 biomarkers detection using various biosensing technologies: |
| |
|
| |
Bioelectronics (including biocomputing, bio-fuel and photovoltaic cells, and electronic noses) |
| |
Commercial biosensors, manufacturing and markets |
| |
DNA- and nucleic acid-based sensors and aptasensors including PCR-related ones. |
| |
Graphene / 2DM based biosensors |
| |
Immunosensors |
| |
Lab-on-a-chip and multiplexed sensors |
| |
Microfluidics and immobilisation technology |
| |
Nanobiosensors, nanomaterials & nanoanalytical systems |
| |
Natural & synthetic receptors (including MIPs) |
| |
Novel transducers |
| |
Printed biosensors and microfabrication |
| |
Rapid methods for the detection of viruses |
| |
Smartphone diagnostics, and mobile health |
| |
Theranostics aspects related to virus diagnostics and therapies connection |
| |
Other methods that might be of interest for virus detections |
